ARTICLE | Clinical News
Remicade infliximab regulatory update
October 18, 2004 7:00 AM UTC
The EC granted marketing approval of Remicade to treat active and progressive psoriatic arthritis in combination with methotrexate in patients not responding to disease modifying anti-rheumatic drugs ...